Latest pharma updates on Mergers & Partnerships
NEC, JFCR & Taiho to Develop Shared-Neoantigen Cancer Vaccines
NEC, together with the Japan Cancer Research Institute (JFCR) and Taiho Pharmaceutical, publicized a partnership to crea...
Read Full Story